US cardiology market price
2023
US $16.67 billion
2030
US $25.60 billion
CAGR (compound annual growth rate)
6.32%
(2024-2030)
Cardiovascular disease (CVD)
#1 reason for death in the U.S.
Market increasers
Upward growth in cardiovascular sickness due to:
- Weight problems
- High blood pressure
- Diabetes
Technology advancements
Minimally invasive methods
Imagining techniques
Material advancements
Wearables
Remote monitoring
Benefits of technology advancements
Enhance patient results
Lessen healing times
Increase efficiency of cardiovascular treatments
Technology used ranges from echocardiography machines and stress tests to catheterization labs.
Key players in the cardiovascular market
Abbott Laboratories
Boston Scientific Corp.
Edwards Lifesciences
Cardinal Health Inc.
Medtronic PLC
GE Healthcare
Johnson & Johnson Services, Inc.
Siemens Healthcare GmbH
https://www.researchandmarkets.com/report/united-states-cardiovascular-devices-market

ICONS: ADOBE STOCK

Explore the May 2024 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- MedTech Innovator welcomes five new industry partners
- First Article Inspection for quality control
- The manufacturing resurgence is here – are you ready?
- Workholding solutions for your business
- ZOLLER events will showcase the company’s cutting-edge innovations
- THINBIT’s MINI GROOVE ‘N TURN Acme threading inserts
- CMMC Roll Out: When Do I Need to Comply? webinar
- Metabolic research uses Siemens gas analyzers to deliver results with 99.9999% resolutions